# Comparison of the Time to Recurrence Between Ranibizumab and Aflibercept

> **NCT02126904** · — · UNKNOWN · sponsor: **Yokohama City University Medical Center** · enrollment: 200 (estimated)

## Conditions studied

- The Injection Burden

## Interventions

- **DRUG:** IVA group

## Key facts

- **NCT ID:** NCT02126904
- **Lead sponsor:** Yokohama City University Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-01
- **Primary completion:** 2013-10
- **Final completion:** —
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2014-04-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02126904

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02126904, "Comparison of the Time to Recurrence Between Ranibizumab and Aflibercept". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02126904. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*